IRAK1 is a novel DEK transcriptional target and is essential for head and neck cancer cell survival

Allie K. Adams(University of Cincinnati), Susanne I. Wells(Cincinnati Children's Hospital Medical Center)
Oncotarget
October 26, 2015
Cited by 42


Related Papers